Dis-Chem Pharmacies (JSE:DCP) Cash And Cash Equivalents : R884 Mil (As of Feb. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Dis-Chem Pharmacies Cash And Cash Equivalents?

Dis-Chem Pharmacies's quarterly cash and cash equivalents increased from Feb. 2023 (R287.39 Mil) to Aug. 2023 (R788.89 Mil) and increased from Aug. 2023 (R788.89 Mil) to Feb. 2024 (R884.37 Mil).

Dis-Chem Pharmacies's annual cash and cash equivalents declined from Feb. 2022 (R705.85 Mil) to Feb. 2023 (R287.39 Mil) but then increased from Feb. 2023 (R287.39 Mil) to Feb. 2024 (R884.37 Mil).

Dis-Chem Pharmacies Cash And Cash Equivalents Historical Data

The historical data trend for Dis-Chem Pharmacies's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dis-Chem Pharmacies Cash And Cash Equivalents Chart

Dis-Chem Pharmacies Annual Data

Trend

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Cash And Cash Equivalents

Get a 7-Day Free Trial

451.84

539.73

705.85

287.39

884.37

Dis-Chem Pharmacies Semi-Annual Data
	Feb14	Feb15	Aug15	Feb16	Aug16	Feb17	Aug17	Feb18	Aug18	Feb19	Aug19	Feb20	Aug20	Feb21	Aug21	Feb22	Aug22	Feb23	Aug23	Feb24
Cash And Cash Equivalents	Get a 7-Day Free Trial															705.85	1,047.71	287.39	788.89	884.37

Dis-Chem Pharmacies Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Dis-Chem Pharmacies (JSE:DCP) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Dis-Chem Pharmacies Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Dis-Chem Pharmacies's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Dis-Chem Pharmacies (JSE:DCP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dis-Chem Pharmacies Ltd (JSE:DCP) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

23 Stag Road, Glen Austin, Midrand, Johannesburg, GT, ZAF, 1685

Website

https://www.dischem.co.za

Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceutical and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries its business operations principally in South Africa.